China Aoxing Pharmaceutical Company
China Aoxing Pharmaceutical Company, Inc. is a pharmaceutical company located in China specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products.
It also has a strategic alliance with American Oriental Bioengineering, Inc. (NYSE: AOB) to develop and market various narcotic drugs in China
See more information about China Aoxing Pharmaceutical Company
China Aoxing receives SFDA approval for clinical trial of abuse resistant Opioid
China Aoxing Pharmaceutical Company, Inc. (OTC:CAXG), has announced that its clinical trial application for Tilidine/Naloxone Capsules, an abuse-resistance opioid drug, was officially approved by the China State Food and Drug Administration.
Opioid drugs are commonly abused by being crushed or dissolved in alcohol to produce a feeling of euphoria.
The company hopes to begin the clinical trial by the end of this year, and estimates that receipt of a market license could occur sometime in 2011. The drug is designated as a Class III New Medicine with approximately at least three-year market exclusivity protection upon marketing clearance by the China SFDA.
Tilidine/Naloxone Capsules were developed with China Aoxing's proprietary technology, which combines Tilidine, an effective opioid agonist, with Naloxone, an opioid antagonist, to address moderate to severe pain, such as cancer pain and post-operative pains.
Based on clinical trials in Europe, when Tilidine/Naloxone Capsules were taken as directed, pain relief was provided and Naloxone passed through the body without observed clinical effect. And if they are crushed or dissolved in alcohol the euphoric effect of Tilidine was significantly reduced
"We remain excited about the growth prospects for abuse resistant painkiller in China, which just becomes a new therapeutic paradigm in developed countries," stated Zhenjiang Yue, Chairman and CEO of China Aoxing.
Other China Aoxing Pharmaceutical Company news
- China Aoxing posts 27pct rise in annual revenue
2009-10-15 - China Aoxing Pharma gets renewal of GMP certification for capsule production facility
2009-07-24
